BioLegend Licenses Single-Cell Analysis Technology from New York Genome Center

Jan 11, 2018

|

NEW YORK (GenomeWeb) – BioLegend has licensed a multidimensional single-cell analysis technology from the New York Genome Center and is collaborating with the center on further research, the two organizations said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Hundreds and Hundreds Retracted

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

Guilty Plea in Kickback Case

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

Florida Bill Moves Ahead

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

Science Presents Studies Into Disease-Causing Mutations Among Bone Marrow Donors; Links Between Heavy Drinking, Other Disease

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.

Menu

BioLegend Licenses Single-Cell Analysis Technology from New York Genome Center

To read the full story....

Breaking News

People in the News: Jay Flatley, Thomas Slavin, Tony Pare, More

In Brief This Week: PerkinElmer, ArcherDx, Geneoscopy, and More

New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, MGI

Novacyt Inks French Distribution Deal for Primerdesign Animal Health Testing Products

Rare CNVs Associated With Major Disease Categories in Large Study of European Subjects

Charles River Partners With Fios Genomics for Analytics Services

The Scan

Hundreds and Hundreds Retracted

Guilty Plea in Kickback Case

Florida Bill Moves Ahead

Science Presents Studies Into Disease-Causing Mutations Among Bone Marrow Donors; Links Between Heavy Drinking, Other Disease

What's Popular?

JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex

JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More

JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics

Revocation of Broad Institute CRISPR Patent Upheld in Europe

Judge Dismisses Lawsuit Accusing Illumina, Affymetrix of Fraud, Theft of Trade Secrets

Sponsorships